Turner Syndrome Market Report 2032: Epidemiology Data, Treatment Market, Drugs, FDA Approvals and Companies by DelveInsight | Pfizer, Novartis AG, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Abbott

April 28 17:09 2023
Turner Syndrome Market Report 2032: Epidemiology Data, Treatment Market, Drugs, FDA Approvals and Companies by DelveInsight | Pfizer, Novartis AG, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Abbott
Turner Syndrome Market

(New York, USA) DelveInsight’s “Turner Syndrome Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Turner Syndrome market trends in the seven major markets (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The report also covers provides insights into the emerging drugs, current treatment practices, market share of the individual therapies, market drivers, barriers, unmet medical needs, current and forecasted market size from 2019 to 2032 segmented by 7MM.


Request for Sample pages @ Turner Syndrome Market Forecast


Turner Syndrome Market Key Facts

  • According to DelveInsight, Turner syndrome market is expected to grow at a decent CAGR by 2032.
  • Leading turner syndrome companies working in the treatment market are Pfizer Inc., Novartis AG, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd, Abbott, Eli Lilly And Company., Bausch Health Companies Inc., Astrazeneca, AbbVie Inc., Allergan, Smiths Group plc, Lupin Pharmaceuticals, Inc., Medtronic, Sanofi, GlaxoSmithKline plc., Sandoz International GmbH, Novo Nordisk A/S, American Gene Technologies, Codexis., BioMarin, Ultragenyx Pharmaceutical and others.
  • According to NORD, Turner Syndrome affects approximately 1 in 2,000‒2,500 live female births.
  • As per National Health Service, 1 in every 1,800 girls has Turner Syndrome in the UK.
  • According to the National Health Service, in about half of the cases of Turner Syndrome, one X chromosome is missing or abnormal, but not in all cells of the body. This is referred to as “Mosaic Turner Syndrome.”
  • According to the article by Nielsen et al., Turner Syndrome occurs in approximately 1 in 1,893 live female births, based on epidemiological and newborn genetic screening data.


Turner Syndrome Disease Overview

Turner syndrome is a rare chromosomal disorder that affects females only. The disorder is characterized by partial or complete loss (monosomy) of one of the chromosomes.  Turner syndrome is highly variable and can differ dramatically from one person to another. Many features of this disorder are nonspecific, and others may develop slowly over time or can be subtle.

Almost all females with Turner syndrome exhibit growth failure and attain a final height that is shorter than average (short stature). Another common feature of Turner syndrome is the failure of the ovaries to develop properly (gonadal dysgenesis). Affected females may develop learning disabilities, especially difficulties with visual-spatial relationships. Many physical abnormalities occur in this condition, such as down-turning eyelids, low-set, prominent ears, neck webbing, etc.


Learn more about Turner Syndrome treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/sample-request/turner-syndrome-market


Turner Syndrome Market

The Turner Syndrome market outlook section of the report helps to understand the historical, current, and forecasted Turner Syndrome market size by analyzing the impact of current therapies on the market, unmet needs, and demand for better technology.

The report gives a thorough detail of key trends, ongoing developments, and growth opportunities of each marketed and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, mechanism of action, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders in the domain.

Turner Syndrome Market is expected to increase in the coming years owing to the expected launch of potential therapies, along with the increasing female population and growth in the biotechnology sector. There are many opportunities for pharmaceutical companies to develop novel therapies for treating Turner Syndrome due to limited therapeutic options available in the market.


Get the PDF Sample of the Report@ https://www.delveinsight.com/sample-request/turner-syndrome-market


Turner Syndrome Epidemiology

The Turner Syndrome epidemiology section covers insights into the historical and current Turner Syndrome patient pool and forecasted trends for every seven major markets from 2019 to 2032.

It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends, along with assumptions undertaken.


Discover more about the epidemiological segmentation@ https://www.delveinsight.com/sample-request/turner-syndrome-market


Turner Syndrome Drugs Uptake and Key Market Players

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Turner Syndrome market or expected to be launched during the study period. The analysis covers the drug uptake, patient uptake by therapies, and sales of each drug.

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake and reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Turner Syndrome Pipeline Development Activities and provides valuable insights about different therapeutic candidates in various stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent development such as collaborations, acquisitions, mergers, licensing patent details, and other information.


Turner Syndrome Therapeutics Analysis

The current clinical pipeline of Turner syndrome is very narrow, as most of the companies are focusing only on the biosimilar of Somatropin (r-DNA) for injection. Patients with Turner syndrome have to cope with many difficulties; they need lifelong medical surveillance and psychological care and treatment for a good outcome.

The Turner Syndrome market dynamics are anticipated to change in the coming years owing to the rise in prevalence of the disease.

At present, few companies are actively working on treating patients with Turner Syndrome, such as Lumos Pharma (LUM-201) and others.


Get More Detailed Insights into the Emerging Turner Syndrome Therapies & Key Companies @ https://www.delveinsight.com/sample-request/turner-syndrome-market


Anaphylaxis Report Key Insights

1. Turner Syndrome Patient Population

2. Turner Syndrome Market Size and Trends

3. Key Cross Competition in the Turner Syndrome Market

4. Turner Syndrome Market Dynamics (Key Drivers and Barriers)

5. Turner Syndrome Market Opportunities

6. Turner Syndrome Therapeutic Approaches

7. Turner Syndrome Pipeline Analysis

8. Turner Syndrome Current Treatment Practices/Algorithm

9. Impact of Emerging Therapies on the Turner Syndrome Market


Table of Content

  1. Key Insights
  2. Executive Summary
  3. Turner Syndrome Competitive Intelligence Analysis
  4. Turner Syndrome Market Overview at a Glance
  5. Turner Syndrome Disease Background and Overview
  6. Turner Syndrome Patient Journey
  7. Turner Syndrome Epidemiology and Patient Population
  8. Turner Syndrome Treatment Algorithm, Current Treatment, and Medical Practices
  9. Turner Syndrome Unmet Needs
  10. Key Endpoints of Turner Syndrome Treatment
  11. Turner Syndrome Marketed Products
  12. Turner Syndrome Emerging Therapies
  13. Turner Syndrome Seven Major Market Analysis
  14. Attribute Analysis
  15. Turner Syndrome Market Outlook (7 major markets)
  16. Turner Syndrome Access and Reimbursement Overview
  17. KOL Views on the Turner Syndrome Market.
  18. Turner Syndrome Market Drivers
  19. Turner Syndrome Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 


About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting